Kiwa Bio-Tech Products Group Corporation
KWBT · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Revenue | $40,089 | $30,650 | $17,270 | $9,618 |
| % Growth | 30.8% | 77.5% | 79.6% | – |
| Cost of Goods Sold | $30,757 | $22,392 | $11,846 | $7,672 |
| Gross Profit | $9,332 | $8,258 | $5,424 | $1,945 |
| % Margin | 23.3% | 26.9% | 31.4% | 20.2% |
| R&D Expenses | $0 | $123 | $148 | $224 |
| G&A Expenses | $4,380 | $4,929 | $2,997 | $874 |
| SG&A Expenses | $4,580 | $5,546 | $3,480 | $923 |
| Sales & Mktg Exp. | $200 | $617 | $483 | $49 |
| Other Operating Expenses | $2,411 | -$1 | $0 | $0 |
| Operating Expenses | $6,991 | $5,669 | $3,628 | $1,148 |
| Operating Income | -$1,186 | $2,589 | $1,796 | $798 |
| % Margin | -3% | 8.4% | 10.4% | 8.3% |
| Other Income/Exp. Net | -$3,789 | -$339 | $121 | $592 |
| Pre-Tax Income | -$4,975 | $2,250 | $1,917 | $1,390 |
| Tax Expense | $1,660 | $1,906 | $1,103 | $426 |
| Net Income | -$6,635 | $344 | $5,309 | $963 |
| % Margin | -16.6% | 1.1% | 30.7% | 10% |
| EPS | -0.29 | 0.021 | 0.51 | 0.17 |
| % Growth | -1,494.2% | -95.9% | 200% | – |
| EPS Diluted | -0.29 | 0.021 | 0.43 | 0.09 |
| Weighted Avg Shares Out | 22,814 | 16,522 | 10,472 | 5,162 |
| Weighted Avg Shares Out Dil | 22,814 | 16,522 | 12,542 | 10,585 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,944 | $635 | $524 | $113 |
| Depreciation & Amortization | $48 | $28 | $46 | $24 |
| EBITDA | -$983 | $2,616 | $2,225 | $1,604 |
| % Margin | -2.5% | 8.5% | 12.9% | 16.7% |